Yupeng Cao1,2, Jun Zhao1,2, Weinan Tang3, Wentao Liu1, and Dong Han1,2
1National Center for Nanoscience and Technology, Beijing, China, 2University of Chinese Academy of Sciences, Beijing, China, 3Wandong Medical Technology, Beijing, China
Synopsis
The combination of DCE and DSC
MRI contribute to the higher accuracy of diagnosis than either alone. However,
high spatial-temporal resolution sequences for DCE and DSC are absent in the
clinical use. Herein, we propose an improved Spiral-Out-In (iSOI) sequence to simultaneously sample DCE and DSC signal with high spatial
resolution. A model-based strategy for reconstruction of 8-fold accelerated MRI
were employed to realize high temporal resolution imaging. The in-plane spatial
resolution is 0.78 mm and the temporal resolution is 0.52 s. The perfusion
parameters were calculated to verify the proposed method which has potential to
benefit the accurate diagnosis.
Introduction
Dynamic
Contrast Enhanced (DCE) and Dynamic Susceptibility Contrast (DSC) MRI are two
non-invasive perfusion imaging techniques widely applied to detect the vessel
permeability and blood flow respectively. The combination of these
two modalities gives more benefit diagnosis results than either alone. However,
the potential nephrotoxity of full dose gadolinium-based contrast agents is
well recognized and the growing evidence that gadolinium deposition may occur
in the brain following repeated exposures. 1,2,3 Hence, the
single-dose perfusion imaging combined DCE and DSC MRI is necessary. In
addition, conventional DCE-MRI is implemented with FLASH and performs high
spatial resolution but the temporal resolution is low. 4 While
conventional DSC-MRI is implemented with single-shot GRE-EPI and performs high
temporal resolution but the spatial resolution is low.5 Both high
spatial and temporal resolutions are important to the diagnosis accuracy in
DCE- and DSC-MRI.6 Herein, we propose an improved Spiral-Out-In
(iSOI) sequence to implement DCE and DSC MRI for high spatial-temporal
resolution brain imaging at a clinical 1.5 Tesla (T) MRI with a single-dose
administration of contrast agents. Interleaved spirals were used to realize the
high spatial resolution and reduce the off-resonance effect. A model-based methods were used to reconstruct the images for the high
temporal resolution DCE- and DSC-MRI.Methods
A study was performed on five healthy beagle canines with intravenous
25% mannitol (25 ml/kg) to open the blood-brain barrier (BBB) that underwent
perfusion analysis. All studies were performed on an iSPACE 1.5 T MRI scanner
(Wandong Medical Inc, Beijing, China) equipped with 3.3 G/cm gradients and 110 mT/m/ms
slew rate. 8-channel phased array coil was used. Pre-contrast T1,
M0 mapping and perfusion weighted imaged were performed using
a multi-shot, dual gradient-echo, spiral-out and -in sequence with the
following parameters: FOV=15×15 cm2,
matrix=192×192, slice thickness=5 mm, skip=1.5 mm,
TE1=4 msec, TE2=34.2 msec, TR=260 msec, number
of slices=4, number of interleaved arms=16. Pre-contrast T1, M0
mapping used flip angle=10°, 15°, 20°, 25°, 35°. Perfusion weighted imaging
used flip angle=60°, number of samples=90. A standard dose of Gadopentetate
Dimeglumine Injection (0.2 mmol/kg, magnevist) was injected at the 30th time
point using a power injector. The spiral trajectory is customized for the
spiral-out and -in part to two contrast echo signals. The high frequency part
in k-space can be shared to reconstruction. Thus the acquisition window width can
be controlled. A combined strategy of parallel imaging, compressed sensing, and
manifold learning was used for spiral image reconstruction and perfusion
calculations were performed offline by using Matlab.Results
Figure
1 displays the multi-shot dual-echo spiral
sequence
diagram. TE1 is 1st echo time and TE2 is 2nd echo time of
this spiral sequence. The first spiral-out echo is used to collect DCE data,
and the second spiral-in echo is used to collect DSC data. Figure 2(a) and (e)
display the reconstructed spiral images from 1st and 2nd
of the perfusion-weighted images for the brain of beagle
canines with intravenous mannitol, respectively. The in-plane resolution is
0.78mm and the temporal resolution is 0.52 second. The structure of the canine
brain is clearly shown. The representative signal intensity time courses displayed
in Figure 2(b) shows the signal intensity time courses of the two echoes,
respectively. Estimates of Ktrans and Vp obtained from Patlak model fitting show
the BBB open after mannitol injection in Figure 2(c) and (d).
Figure 2(f) displays R1 changes and R2*
changes of brain from DCE signals (red curve) and DSC
signals (blue curve) respectively. Estimates of CBF and CBV are displayed in
Figure 2(g) and (h). These results suggest that both DSC and DCE
parameters can be obtained simultaneously using a multi-shot iSOI acquisition
method with a standard dose of contrast agent. Discussion
This
sequence can realize DCE and DSC in a single-dose scan. The repetition time (TR) is
crucial to the contrast type. Hence, an optimum TR should be
considered. Ultra-short TR which enables fast scan is not suitable with this
sequence. After mannitol injection, the BBB will open and the contrast agent
will perfuse into the brain of canines. Therefore, signal intensity-time curves
of both echoes show perfusion-like. The relaxivity changes can be used to
calculate the arterial input function, which is important for the DCE.7 Noteworthy, the R2* is robust to noise which this
sequence can obtained. As a result, the DSC data can be used to optimum
calculations of DCE perfusion parameters. Estimations of Ktrans, Vp, CBV and
CBF show the brain perfusions.Conclusion
We
have presented the theory and feasibility of a dual-echo spiral-based perfusion
imaging method by which DSC-and DCE-MRI perfusion imaging data can be derived
simultaneously, with high temporal and spatial resolution using only a single
dose of contrast agent. This approach has several distinct advantages over the
more common approach of obtaining DSC and DCE data separately and with
different imaging sequences. An important advantage of the approach is that all
data can be obtained using only a single-dose contrast agent. This advantage is
of particular importance given the recent restrictions implemented by the Food
and Drug Administration on the use of Gd-based agents because of the small but
real risk of nephrogenic systemic fibrosis and more recent concerns regarding
Gd deposition in brain. Acknowledgements
This
work was supported by the National Natural Science Foundation of China (NSFC)
(No. 61971151)References
1. McDonald R,
McDonald J, Newhouse J, et al. Controversies in contrast material-induced acute
kidney injury: closing in on the truth? Radiology 2015; 277: 627–632.
2. Kanal E,
Tweedle M. Residual or retained gadolinium: practical implications for
radiologists and our patients. Radiology 2015;275: 630–634.
3. McDonald R,
McDonald J, Kallmes D, et al. Gadolinium deposition in human brain tissues
after contrast-enhanced MR imaging in adult patients without intracranial
abnormalities. Radiology 2017;285: 546–554.
4.
Marica C, David L, Patrick W, et al. Comparison of ASL and DCE MRI for the
non-invasive measurement of renal blood flow: quantification and
reproducibility. Eur Radiol 2014; 24:1300–1308.
5.
Simon L, Pierre R, Maxime G, et al. Feasibility of human spinal cord
perfusion mapping using dynamic susceptibility contrast imaging at 7T:
Preliminary results and identified guidelines. 2020; 00: 1–12.
6.
Lindsay W. Dynamic contrast-enhanced MRI in the diagnosis and management of
breast cancer. NMR IN BIOMEDICINE 2009; 22: 28-39.
7.
McDonald R, McDonald J, Kallmes D, et al. Intracranial gadolinium deposition
after contrast-enhanced MR imaging. Radiology 2015; 275 (3): 772–782.